A T-cell test developed by Adaptive Biotechnologies could become the first commercially available test of its kind, and it may be more effective at detecting past COVID-19 infections than antibody ...
HC Wainwright initiated coverage on Virax Biolabs with a Buy rating and a $3 price target, citing strong market potential. ViraxImmune platform aims to diagnose T-cell exhaustion in post-viral ...
CAR T cells are patient-derived, genetically engineered immune cells. They are "living drugs" and constitute a milestone in modern medicine. Equipping T cells, a key cell type of the immune system, ...
Providing vital health care services to people in developing countries without reliable electricity, refrigeration and state-of-the-art medical equipment poses a number of challenges. Inspired by ...
5don MSN
'Primed and ready': How one fast-acting type of white blood cell fights off infection in infants
From the moment they're born, newborns—or, specifically, their immune systems—must learn to fight germs without harming their ...
SEATTLE, June 15, 2022 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into ...
Telomere damage drives T cell exhaustion. Antioxidants restored their cancer-fighting strength in mice. Tumor environments place heavy stress on immune cells that fight cancer. Limited oxygen, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback